TCL Archive In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads August 8, 1980
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive DCPC Board Kills Cost Sharing for CIS, Rejects Primary Care Prevention Effort Evaluation Budget May 13, 1988
TCL Archive National Coalition Dinner Honors Cancer Program Founders, Advocates, And Cancer Survivors March 6, 1992
TCL Archive New Therapies For Genitourinary Cancers In Clinical Testing Presented At ASCO July 25, 2003
